Back to search
FDAFDA · Food and drugs·Recall number Z-1506-2023

DERMLITE DL4W, REF: DL4W, Rx Only MD, CE

Published May 10, 2023 · Recall initiated: March 20, 2023

Summary

FDA records medical device Class II recall Z-1506-2023, published May 10, 2023 and initiated March 20, 2023. Recalling firm: DermLite LLC; Status: Ongoing; Reported quantity: 32 units; Lot: Lot # 7654, serial numbers DL4WGXXXX & DL4WBXXXX (1304-1353 and 1504); UDI-DI: (01) 0 8559970. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect labeling; Package labeling contains a different serial number then the serial number on the product labeling.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
DermLite LLC
Distributor
Worldwide - US Nationwide distribution in the states of CA, AZ, TX, FL, NE, IA, MO, CO and the countries of Saudi Arabia, Australia, Spain.
Lot
Lot # 7654, serial numbers DL4WGXXXX & DL4WBXXXX (1304-1353 and 1504); UDI-DI: (01) 0 8559970
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was DERMLITE DL4W, REF: DL4W, Rx Only MD, CE recalled?

Yes. FDA published recall Z-1506-2023 on May 10, 2023. Reported hazard: Incorrect labeling; Package labeling contains a different serial number then the serial number on the product labeling.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone